🔎 Trials Near Me

ホーム › 直腸がん › ニューヨーク

ニューヨークにおける直腸がんの臨床試験

ニューヨーク内の拠点で、直腸がんに関する22件の研究が参加者を募集しています。

ニューヨーク内の都市

公式研究テキスト(英語)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • James J Peters VA Medical Center, The Bronx
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939

Family Communications After Genetic Testing

  • Glens Falls Hospital, Glens Falls
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • Memorial Sloan Kettering Cancer Center ( Site 0095), New York
  • Ellis Hospital ( Site 0098), Schenectady
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

  • Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07227636

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • NYU Langone Health Perlmutter Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

  • Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
  • Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04165772

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • University of Rochester Medical Center, Rochester
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/09/02更新 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

  • Weill Cornell Medical College, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
被験者募集中第2相
18歳〜90歳 · 全性別 · 2026/07/29更新 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06205485

Integrated Cancer Repository for Cancer Research

  • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
  • Faxton St. Luke's Healthcare, Mohawk Valley, Utica
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

  • New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
  • Weill Cornell Medical College, New York
  • New York Presbyterian Hospital - Queens, New York
被験者募集中
18歳〜90歳 · 全性別 · 2026/06/15更新 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • NYU Langone Medical Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • 他1件
被験者募集中
18歳以上 · 全性別 · 2026/06/02更新 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

  • Columbia University Irving Medical Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/13更新 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

  • Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/12更新 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

  • Memorial Sloan Kettering Cancer Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

  • Columbia University Irving Medical Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/25更新 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Buffalo
  • Massive Bio SYNERGY-AI site, Hempstead
  • Massive Bio SYNERGY-AI site, Manhasset
  • 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

  • Bassett Healthcare Network, Cooperstown
被験者募集中観察研究
18歳以上 · 全性別 · 2023/03/07更新 · NCT04245683

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。